These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15040942)

  • 1. Clearance of Helicobacter pylori infection through immunization: the site of T cell activation contributes to vaccine efficacy.
    Blanchard TG; Eisenberg JC; Matsumoto Y
    Vaccine; 2004 Feb; 22(7):888-97. PubMed ID: 15040942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice.
    Matsumoto Y; Blanchard TG; Drakes ML; Basu M; Redline RW; Levine AD; Czinn SJ
    Helicobacter; 2005 Oct; 10(5):407-15. PubMed ID: 16181351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
    Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo.
    Rad R; Brenner L; Bauer S; Schwendy S; Layland L; da Costa CP; Reindl W; Dossumbekova A; Friedrich M; Saur D; Wagner H; Schmid RM; Prinz C
    Gastroenterology; 2006 Aug; 131(2):525-37. PubMed ID: 16890606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CD4CD25 regulatory T cells.
    Raghavan S; Suri-Payer E; Holmgren J
    Scand J Immunol; 2004; 60(1-2):82-8. PubMed ID: 15238076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation, immunity and vaccines for Helicobacter pylori.
    Del Giudice G; Michetti P
    Helicobacter; 2004; 9 Suppl 1():23-8. PubMed ID: 15347302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization.
    Gottwein JM; Blanchard TG; Targoni OS; Eisenberg JC; Zagorski BM; Redline RW; Nedrud JG; Tary-Lehmann M; Lehmann PV; Czinn SJ
    J Infect Dis; 2001 Aug; 184(3):308-14. PubMed ID: 11443556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current status of Helicobacter pylori vaccines: a review.
    Kabir S
    Helicobacter; 2007 Apr; 12(2):89-102. PubMed ID: 17309745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori immunology and vaccines.
    Vorobjova T; Watanabe T; Chiba T
    Helicobacter; 2008 Oct; 13 Suppl 1():18-22. PubMed ID: 18783517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
    Akhiani AA; Stensson A; Schön K; Lycke N
    Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAR2 promotes vaccine-induced protection against Helicobacter infection in mice.
    Velin D; Narayan S; Bernasconi E; Busso N; Ramelli G; Maillard MH; Bachmann D; Pythoud C; Bouzourene H; Michetti P; So A
    Gastroenterology; 2011 Oct; 141(4):1273-82, 1282.e1. PubMed ID: 21703999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Helicobacter pylori infection.
    Lee A
    Scand J Gastroenterol Suppl; 1996; 215():11-5. PubMed ID: 8722377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in vaccination against Helicobacter pylori.
    Velin D; Michetti P
    Expert Rev Gastroenterol Hepatol; 2010 Apr; 4(2):157-66. PubMed ID: 20350263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
    Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
    Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies.
    Wilson KT; Crabtree JE
    Gastroenterology; 2007 Jul; 133(1):288-308. PubMed ID: 17631150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
    Nyström J; Svennerholm AM
    Vaccine; 2007 Mar; 25(14):2591-8. PubMed ID: 17239498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori vaccine development: optimisation of strategies and importance of challenging strain and animal model.
    Hoffelner H; Rieder G; Haas R
    Int J Med Microbiol; 2008 Jan; 298(1-2):151-9. PubMed ID: 17714988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, immunity, vaccines for Helicobacter infection.
    Chmiela M; Michetti P
    Helicobacter; 2006 Oct; 11 Suppl 1():21-6. PubMed ID: 16925607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori.
    Flach CF; Svensson N; Blomquist M; Ekman A; Raghavan S; Holmgren J
    Vaccine; 2011 Feb; 29(6):1235-41. PubMed ID: 21147129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against Helicobacter pylori infection in mongolian gerbil by intragastric or intramuscular administration of H. pylori multicomponent vaccine.
    Wu C; Shi Y; Guo H; Zou WY; Guo G; Xie QH; Mao XH; Tong WD; Zou QM
    Helicobacter; 2008 Jun; 13(3):191-9. PubMed ID: 18466394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.